WATCH: New Developments in Drugs to Reduce Inflammation, Feb. 2016

Dr. James Chmiel shares new developments in drugs to reduce inflammation in the lungs and help prevent lung damage.

| 1 min read
Christina Roman

Welcome to the second installment in our video series highlighting the ways Cystic Fibrosis Foundation Therapeutics (CFFT) and industry are tackling cystic fibrosis from every angle. This week's topic explores the anti-inflammatory category in CFFT's drug development pipeline.

Dr. James Chmiel discusses new approaches to treat inflammation and explains why it is so important to address this issue. When people with CF develop lung infections, they tend to have an exaggerated inflammation response. This exaggerated response is responsible for much of the lung damage associated with CF and actually can be worse than the infection itself.

If you didn't catch our recent post on CFTR modulators, check it out here. And stay tuned for more videos about ongoing research.

To learn more about drugs that are in development, visit our drug development pipeline. Or if you would like to search for a clinical trial, visit the clinical trial search tool.

This site contains general information about cystic fibrosis, as well as personal insight from the CF community. Opinions and experiences shared by members of our community, including but not limited to people with CF and their families, belong solely to the blog post author and do not represent those of the Cystic Fibrosis Foundation, unless explicitly stated. In addition, the site is not intended as a substitute for treatment advice from a medical professional. Consult your doctor before making any changes to your treatment.

Share this article
Research | Drug Pipeline | Cystic Fibrosis Foundation Therapeutics (CFFT) | Clinician Resources

As community engagement manager for the Cystic Fibrosis Foundation, Christina works to help embed the voice of the community into the work of the Foundation. Before joining the community partnerships team Christina worked on the clinical trials team for 3 years and at Colorado Children's Hospital for 2 years supporting the CF team. She holds a master's degree in public health from the University of Colorado. Originally from Estes Park, Colo., Christina now lives in Washington, D.C., with her husband.

Recent Community Posts
Finding Normalcy After Transplant
Blog | 5 min read
How One Diagnosis Can Change Everything
Blog | 7 min read
Navigating the Emotions of Chronic Lung Rejection
Blog | 7 min read